Ticker Symbol: XCUR
Exicure Inc
$0.77 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001698530
Company Profile
Exicure, Inc. is a clinical-stage biotechnology company developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on its proprietary Spherical Nucleic Acid, or SNA technology. Exicure believes its proprietary SNA architecture has distinct chemical and biological properties that may provide advantages over other nucleic acid therapeutics and may have therapeutic potential to target diseases not typically addressed with other nucleic acid therapeutics. Exicure's lead program is cavrotolimod (AST-008) which is being evaluated in a Phase1b/2 clinical trial in patients with advanced solid tumors. Exicure is based in Chicago, IL.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 8045 Lamon Ave Ste 410
Website: www.exicuretx.com
CEO: David Giljohann
Tags:
- Miscellaneous Commercial Services
- Commercial Services
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.73
Change:
-$0.01
(
-1.62%)
Days Range: $0.72 - $0.74
Beta: 0.28
52wk. High: $1.78
52wk. Low: $0.63
Ytd. Change -37.10%
50 Day Moving Average: $0.75
200 Day Moving Average: $0.95
Shares Outstanding: 8648307
Valuation
Market Cap: 631.3M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A